851684-46-3

Basic information

• Product Name: N-(3-Chloro-4-(3-fluorobenzyloxy)phenyl)-6-iodoquinazolin-4-aMine drochloride
• Synonyms: N-(3-CHLORO-4-(3-FLUOROBENZYLOXY)PHENYL)-6-IODOQUINAZOLIN-4-AMINE DROCHLORIDE;N-[3-Chloro-4-[(3-fluorobenzyl)oxy]phenyl]-6-iodoquinazolin-4-amine Hydrochloride
• CAS NO: 851684-46-3
• Molecular Formula: C₂₁H₁₄ClFIN₃O*ClH
• Mol File: 851684-46-3.mol
• Article Data: 5

Chemical Properties

• Appearance: /
• Storage Temp.: -20°C Freezer
• Solubility: DMSO (Slightly), Methanol (Slightly, Heated)
• CAS DataBase Reference: N-(3-Chloro-4-(3-fluorobenzyloxy)phenyl)-6-iodoquinazolin-4-aMine drochloride(CAS DataBase Reference)
• NIST Chemistry Reference: N-(3-Chloro-4-(3-fluorobenzyloxy)phenyl)-6-iodoquinazolin-4-aMine drochloride(851684-46-3)
• EPA Substance Registry System: N-(3-Chloro-4-(3-fluorobenzyloxy)phenyl)-6-iodoquinazolin-4-aMine drochloride(851684-46-3)

Safety Data

• Hazardous Substances Data: 851684-46-3(Hazardous Substances Data)

Upstream product

• 1373622-18-4 4-chloro-6-iodoquinazoline hydrochloride 
• 202197-26-0 3-chloro-4-(3-fluorobenzyloxy)aniline 
• 5326-47-6 2-amino-5-iodobenzoic acid 
• 16064-08-7 6-iodoquinazolin-4(3H)-one 
• 98556-31-1 4-chloro-6-iodoquinazoline 

Downstream Products

• 697299-73-3 (3-{4-[3-chloro-4-(3-fluoro-benzyloxy)-phenylamino]-quinazolin-6-yl}-prop-2-ynyl)-carbamic acid tert-butyl ester 
• 851545-81-8 4-(3-chloro-4-(3-fluorobenzyloxy)phenylamino)-6-formylquinazoline 
• 908306-43-4 4-(3-chloro-4-(3-fluorobenzyloxy)phenylamino)-quinazoline-6-carboxylic acid methyl ester 
• 1432450-43-5 N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl)-6-(4-(morpholinosulfonyl)phenyl)quinazolin-4-amine 
• 1432450-44-6 N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl)-6-(4-methylnaphthalen-1-yl)quinazolin-4-amine 
• 1432450-45-7 4-(4-((3-chloro-4-((3-fluorobenzyl)oxy)phenyl)amino)-quinazolin-6-yl)-N-ethyl-2-fluorobenzamide 
• 1432450-46-8 N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl)-6-(3-(5-methyl-1,3,4-oxadiazol-2-yl)phenyl)quinazolin-4-amine 
• 1432450-47-9 3-(4-((3-chloro-4-((3-fluorobenzyl)oxy)phenyl)amino)-quinazolin-6-yl)-N-cyclopropylbenzamide 
• 1432450-48-0 N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl)-6-(quinolin-5-yl)quinazolin-4-amine 
• 1432450-49-1 N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl)-6-(2-phenoxyphenyl)quinazolin-4-amine 
• 1432450-50-4 6-(benzo[b]thiophen-2-yl)-N-(3-chloro-4-((3-fluorobenzyl)-oxy)phenyl)quinazolin-4-amine 
• 1432450-51-5 4-(4-((3-chloro-4-((3-fluorobenzyl)oxy)phenyl)amino)-quinazolin-6-yl)phenol 
• 1432450-52-6 5-(4-(((3-chloro-4-(3-fluorobenzyl)oxy)phenyl)amino)-quinazolin-6-yl)pyrimidine-2,4(1H,3H)-dione 
• 1432450-53-7 N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl)-6-(3-(morpholinosulfonyl)phenyl)quinazolin-4-amine 

Relevant articles and documents

Kinase scaffold repurposing for neglected disease drug discovery: Discovery of an efficacious, lapatanib-derived lead compound for trypanosomiasis

Human African trypanosomiasis (HAT) is a neglected tropical disease caused by the protozoan parasite Trypanosoma brucei. Because drugs in use against HAT are toxic and require intravenous dosing, new drugs are needed. Initiating lead discovery campaigns b

QUINAZOLINE DERIVATIVE HAVING TYROSINE KINASE INHIBITORY ACTIVITY

A compound represented by the general formula (I) or a pharmaceutically acceptable salt thereof or a solvate of the compound or the salt: (I) wherein Rx represents a group represented by the formula(II): where R1 represents a hydrogen atom, an alkyl group which may be substituted or the like, Z represents -O-, -N(R10)- or the like, R10 represents a hydrogen atom, an alkyl group or the like, R2 represents a hydrogen atom, an alkyl group which may be substituted or the like, R18 represents a hydrogen atom, an alkyl group which may be substituted or the like, R19 represents an alkyl group which may be substituted or the like, W1 represents a non-aromatic nitrogenated heterocyclic group which may be substituted, and R17 represents a hydrogen atom, an alkyl group which may be substituted or the like; R3 and R4 independently represent a hydrogen atom, an alkyl group which may be substituted or the like; X represents -O-, -S-, -N(R12)- or the like; R12 represents a hydrogen atom, an alkyl group or the like; and A represents a phenyl group which may be substituted or the like. The compound can inhibit both EGF receptor tyrosine kinase and HER2 tyrosine kinase.

CYANOGUANIDINES AND CYANOAMIDINES AS ERBB2 AND EGFR INHIBITORS

-